{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:03:48Z","timestamp":1786982628270,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["mh128108"],"award-info":[{"award-number":["mh128108"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["ag066215"],"award-info":[{"award-number":["ag066215"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Central nervous system (CNS) dysfunction remains prevalent in people with HIV (PWH) despite effective antiretroviral therapy (ART). There is evidence that low-level HIV infection and ART drugs may contribute to CNS damage in the brain of PWH with suppressed viral loads. As cannabis is used at a higher rate in PWH compared to the general population, there is interest in understanding how HIV proteins and ART drugs interact with the endocannabinoid system (ECS) and inflammation in the CNS. Therefore, we investigated the effects of the HIV envelope protein gp120 and tenofovir alafenamide (TAF) on cannabinoid receptor 1 (CB\n                    <jats:sub>1<\/jats:sub>\n                    R), glial fibrillary acidic protein (GFAP), and IBA1 in the brain and on locomotor activity in mice. The gp120 transgenic (tg) mouse model was administered TAF daily for 30 days and then analyzed using the open field test before being euthanized, and their brains were analyzed for CB\n                    <jats:sub>1<\/jats:sub>\n                    R, GFAP, and IBA1 expression using immunohistochemical approaches. CB\n                    <jats:sub>1<\/jats:sub>\n                    R expression levels were significantly increased in CA1, CA2\/3, and dentate gyrus of gp120tg mice compared to wt littermates; TAF reversed these effects. As expected, TAF showed a medium effect of enhancing GFAP in the frontal cortex of gp120tg mice in the frontal cortex. TAF had minimal effect on IBA1 signal. TAF showed medium to large effects on fine movements, rearing, total activity, total distance, and lateral activity in the open-field test. These findings suggest that TAF may reverse gp120-induced effects on CB\n                    <jats:sub>1<\/jats:sub>\n                    R expression and, unlike tenofovir disoproxil fumarate (TDF), may not affect gliosis in the brain.\n                  <\/jats:p>","DOI":"10.1007\/s13365-023-01155-x","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T10:01:34Z","timestamp":1696586494000},"page":"564-576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["GP120 and tenofovir alafenamide alter cannabinoid receptor 1 expression in hippocampus of mice"],"prefix":"10.1007","volume":"29","author":[{"given":"Jacqueline Renee","family":"Kulbe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Anh","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazmin","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Elizabeth","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Swinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Rissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8168-1412","authenticated-orcid":false,"given":"Jerel Adam","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,6]]},"reference":[{"key":"1155_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s12640-016-9608-6","volume":"29","author":"V Avdoshina","year":"2016","unstructured":"Avdoshina V, Fields JA, Castellano P, Dedoni S, Palchik G, Trejo M, Adame A, Rockenstein E, Eugenin E, Masliah E, Mocchetti I (2016) The HIV Protein gp120 Alters Mitochondrial Dynamics in Neurons. Neurotox Res 29:583\u201393","journal-title":"Neurotox Res"},{"key":"1155_CR2","unstructured":"Avraham H, Jiang S, Fu Y, Rockenstein EM, Makriyannis A, Masliah E, Avraham S (2011) CB2 cannabinoid agonists inhibited HIV-1 gp120-induced neurotoxicity of neural progenitor cells and promoted their survival and differentiation. PLoS One Submitted"},{"key":"1155_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.expneurol.2010.03.025","volume":"224","author":"M Bari","year":"2010","unstructured":"Bari M, Rapino C, Mozetic P, Maccarrone M (2010) The endocannabinoid system in gp120-mediated insults and HIV-associated dementia. Exp Neurol 224:74\u201384","journal-title":"Exp Neurol"},{"key":"1155_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000495939","volume":"103","author":"E Bogathy","year":"2019","unstructured":"Bogathy E, Kostyalik D, Petschner P, Vas S, Bagdy G (2019) Blockade of serotonin 2c receptors with sb-242084 moderates reduced locomotor activity and rearing by cannabinoid 1 receptor antagonist AM-251. Pharmacology 103:151\u2013158","journal-title":"Pharmacology"},{"key":"1155_CR5","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1038\/s41598-019-39898-5","volume":"9","author":"P Castellano","year":"2019","unstructured":"Castellano P, Prevedel L, Valdebenito S, Eugenin EA (2019) HIV infection and latency induce a unique metabolic signature in human macrophages. Sci Rep 9:3941","journal-title":"Sci Rep"},{"key":"1155_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0304-3959(01)00454-7","volume":"96","author":"N Clayton","year":"2002","unstructured":"Clayton N, Marshall FH, Bountra C, O\u2019Shaughnessy CT (2002) CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain 96:253\u2013260","journal-title":"Pain"},{"key":"1155_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1365-2990.2011.01177.x","volume":"37","author":"MA Cosenza-Nashat","year":"2011","unstructured":"Cosenza-Nashat MA, Bauman A, Zhao ML, Morgello S, Suh HS, Lee SC (2011) Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities. Neuropathol Appl Neurobiol 37:464\u201383","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1155_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101616","volume":"181","author":"B Cotto","year":"2019","unstructured":"Cotto B, Natarajanseenivasan K, Langford D (2019a) HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders. Prog Neurobiol 181:101616","journal-title":"Prog Neurobiol"},{"key":"1155_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s13365-019-00721-6","volume":"25","author":"B Cotto","year":"2019","unstructured":"Cotto B, Natarajaseenivasan K, Langford D (2019b) Astrocyte activation and altered metabolism in normal aging, age-related CNS diseases, and HAND. J Neurovirol 25:722\u2013733","journal-title":"J Neurovirol"},{"key":"1155_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009313","volume":"5","author":"L Crews","year":"2010","unstructured":"Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E (2010) Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One 5:e9313","journal-title":"PLoS One"},{"key":"1155_CR11","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1046\/j.1460-9568.1999.00857.x","volume":"11","author":"R D'Hooge","year":"1999","unstructured":"D\u2019Hooge R, Franck F, Mucke L, De Deyn PP (1999) Age-related behavioural deficits in transgenic mice expressing the HIV-1 coat protein gp120. Eur J Neurosci 11:4398\u2013402","journal-title":"Eur J Neurosci"},{"key":"1155_CR12","first-page":"526","volume":"29","author":"G Di Perri","year":"2021","unstructured":"Di Perri G (2021) Tenofovir alafenamide (TAF) clinical pharmacology. Infez Med 29:526\u2013529","journal-title":"Infez Med"},{"key":"1155_CR13","doi-asserted-by":"crossref","unstructured":"Donoso M, D'Amico D, Valdebenito S, Hernandez CA, Prideaux B, Eugenin EA (2022) Identification, quantification, and characterization of HIV-1 reservoirs in the human brain. Cells 11","DOI":"10.3390\/cells11152379"},{"key":"1155_CR14","doi-asserted-by":"crossref","unstructured":"Ellis RJ, Peterson SN, Li Y, Schrier R, Iudicello J, Letendre S, Morgan E, Tang B, Grant I, Cherner M (2020) Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood. Neurol Neuroimmunol Neuroinflamm 7","DOI":"10.1212\/NXI.0000000000000809"},{"key":"1155_CR15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/cid\/ciaa437","volume":"73","author":"RJ Ellis","year":"2021","unstructured":"Ellis RJ, Peterson S, Cherner M, Morgan E, Schrier R, Tang B, Hoenigl M, Letendre S, Iudicello J (2021a) Beneficial Effects of Cannabis on Blood-Brain Barrier Function in Human Immunodeficiency Virus. Clin Infect Dis 73:124\u2013129","journal-title":"Clin Infect Dis"},{"key":"1155_CR16","doi-asserted-by":"crossref","unstructured":"Ellis RJ, Wilson N, Peterson S (2021b) Cannabis and inflammation in HIV: A review of human and animal studies. Viruses 13","DOI":"10.3390\/v13081521"},{"key":"1155_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/glia.24246","volume":"71","author":"A Eraso-Pichot","year":"2023","unstructured":"Eraso-Pichot A, Pouvreau S, Olivera-Pinto A, Gomez-Sotres P, Skupio U, Marsicano G (2023) Endocannabinoid signaling in astrocytes. Glia 71:44\u201359","journal-title":"Glia"},{"key":"1155_CR18","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1097\/QAD.0000000000002628","volume":"34","author":"M Ferrara","year":"2020","unstructured":"Ferrara M, Bumpus NN, Ma Q, Ellis RJ, Soontornniyomkij V, Fields JA, Bharti A, Achim CL, Moore DJ, Letendre SL (2020) Antiretroviral drug concentrations in brain tissue of adult decedents. AIDS 34:1907\u20131914","journal-title":"AIDS"},{"key":"1155_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.irn.2019.04.003","volume":"145","author":"JA Fields","year":"2019","unstructured":"Fields JA, Ellis RJ (2019) HIV in the cART era and the mitochondrial: immune interface in the CNS. Int Rev Neurobiol 145:29\u201365","journal-title":"Int Rev Neurobiol"},{"key":"1155_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12974-016-0585-8","volume":"13","author":"JA Fields","year":"2016","unstructured":"Fields JA, Overk C, Adame A, Florio J, Mante M, Pineda A, Desplats P, Rockenstein E, Achim C, Masliah E (2016a) Neuroprotective effects of the immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity. J Neuroinflammation 13:120","journal-title":"J Neuroinflammation"},{"key":"1155_CR21","doi-asserted-by":"crossref","unstructured":"Fields JA, Serger E, Campos S, Divakaruni AS, Kim C, Smith K, Trejo M, Adame A, Spencer B, Rockenstein E, Murphy AN, Ellis RJ, Letendre S, Grant I, Masliah E (2015) HIV alters neuronal mitochondrial fission\/fusion in the brain during HIV-associated neurocognitive disorders. Neurobiol Dis","DOI":"10.1016\/j.nbd.2015.11.015"},{"key":"1155_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nbd.2015.11.015","volume":"86","author":"JA Fields","year":"2016","unstructured":"Fields JA, Serger E, Campos S, Divakaruni AS, Kim C, Smith K, Trejo M, Adame A, Spencer B, Rockenstein E, Murphy AN, Ellis RJ, Letendre S, Grant I, Masliah E (2016b) HIV alters neuronal mitochondrial fission\/fusion in the brain during HIV-associated neurocognitive disorders. Neurobiol Dis 86:154\u201369","journal-title":"Neurobiol Dis"},{"key":"1155_CR23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/jnc.14582","volume":"147","author":"JA Fields","year":"2018","unstructured":"Fields JA, Spencer B, Swinton M, Qvale EM, Marquine MJ, Alexeeva A, Gough S, Soontornniyomkij B, Valera E, Masliah E, Achim CL, Desplats P (2018) Alterations in brain TREM2 and Amyloid-beta levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. J Neurochem 147:784\u2013802","journal-title":"J Neurochem"},{"key":"1155_CR24","doi-asserted-by":"publisher","first-page":"17158","DOI":"10.1038\/s41598-019-53466-x","volume":"9","author":"JA Fields","year":"2019","unstructured":"Fields JA, Swinton MK, Carson A, Soontornniyomkij B, Lindsay C, Han MM, Frizzi K, Sambhwani S, Murphy A, Achim CL, Ellis RJ, Calcutt NA (2019) Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice. Sci Rep 9:17158","journal-title":"Sci Rep"},{"key":"1155_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/01.aids.0000432467.54003.f7","volume":"28","author":"LJ Garvey","year":"2014","unstructured":"Garvey LJ, Pavese N, Politis M, Ramlackhansingh A, Brooks DJ, Taylor-Robinson SD, Winston A (2014) Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS 28:67\u201372","journal-title":"AIDS"},{"key":"1155_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.763448","volume":"12","author":"PJ Gaskill","year":"2021","unstructured":"Gaskill PJ, Fields JA, Langford DT, Stauch KL, Williams DW (2021) Editorial: advances in understanding neurohiv associated changes in neuroimmune communication in the combined anti-retroviral therapy (cART) Era. Front Neurol 12:763448","journal-title":"Front Neurol"},{"key":"1155_CR27","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1093\/jac\/dkab334","volume":"76","author":"T Gele","year":"2021","unstructured":"Gele T, Cheret A, Castro Gordon A, Nkam L, Furlan V, Pallier C, Becker PH, Catalan P, Goujard C, Taburet AM, Gasnault J, Gouget H, Barrail-Tran A (2021) Cerebrospinal fluid exposure to bictegravir\/emtricitabine\/tenofovir in HIV-1-infected patients with CNS impairment. J Antimicrob Chemother 76:3280\u20133285","journal-title":"J Antimicrob Chemother"},{"key":"1155_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.639378","volume":"12","author":"JW George","year":"2021","unstructured":"George JW, Mattingly JE, Roland NJ, Small CM, Lamberty BG, Fox HS, Stauch KL (2021) Physiologically relevant concentrations of dolutegravir, emtricitabine, and efavirenz induce distinct metabolic alterations in hela epithelial and bv2 microglial cells. Front Immunol 12:639378","journal-title":"Front Immunol"},{"key":"1155_CR29","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/QAD.0b013e3283427da7","volume":"25","author":"Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B, Consortium HIVN","year":"2011","unstructured":"Harezlak J, Buchthal S, Taylor M, Schifitto G, Zhong J, Daar E, Alger J, Singer E, Campbell T, Yiannoutsos C, Cohen R, Navia B, Consortium HIVN (2011) Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS 25:625\u201333","journal-title":"AIDS"},{"key":"1155_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, Group C, Group H","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, Group C, Group H (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3\u201316","journal-title":"J Neurovirol"},{"key":"1155_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/apha.12474","volume":"214","author":"L Jean-Gilles","year":"2015","unstructured":"Jean-Gilles L, Braitch M, Latif ML, Aram J, Fahey AJ, Edwards LJ, Robins RA, Tanasescu R, Tighe PJ, Gran B, Showe LC, Alexander SP, Chapman V, Kendall DA, Constantinescu CS (2015) Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells. Acta Physiol (Oxf) 214:63\u201374","journal-title":"Acta Physiol (Oxf)"},{"key":"1155_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jphs.2020.02.003","volume":"143","author":"K Kobayashi","year":"2020","unstructured":"Kobayashi K, Shimizu N, Matsushita S, Murata T (2020) The assessment of mouse spontaneous locomotor activity using motion picture. J Pharmacol Sci 143:83\u201388","journal-title":"J Pharmacol Sci"},{"key":"1155_CR33","first-page":"100463","volume":"12","author":"F Leonard BaA","year":"2023","unstructured":"Leonard BaA F (2023) Cannabinoids and neuroinflammation: Therapeutic implications. J Affect Disord 12","journal-title":"J Affect Disord"},{"key":"1155_CR34","doi-asserted-by":"publisher","first-page":"6406","DOI":"10.4049\/jimmunol.181.9.6406","volume":"181","author":"TS Lu","year":"2008","unstructured":"Lu TS, Avraham HK, Seng S, Tachado SD, Koziel H, Makriyannis A, Avraham S (2008) Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. J Immunol 181:6406\u201316","journal-title":"J Immunol"},{"key":"1155_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1521\/aeap.2018.30.2.169","volume":"30","author":"LR Pacek","year":"2018","unstructured":"Pacek LR, Towe SL, Hobkirk AL, Nash D, Goodwin RD (2018) Frequency of cannabis use and medical cannabis use among persons living with hiv in the united states: findings from a nationally representative sample. AIDS Educ Prev 30:169\u2013181","journal-title":"AIDS Educ Prev"},{"key":"1155_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108626","volume":"195","author":"GN Petrie","year":"2021","unstructured":"Petrie GN, Nastase AS, Aukema RJ, Hill MN (2021) Endocannabinoids, cannabinoids and the regulation of anxiety. Neuropharmacology 195:108626","journal-title":"Neuropharmacology"},{"key":"1155_CR37","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1111\/febs.15907","volume":"289","author":"A Robledo-Menendez","year":"2022","unstructured":"Robledo-Menendez A, Vella M, Grandes P, Soria-Gomez E (2022) Cannabinoid control of hippocampal functions: the where matters. FEBS J 289:2162\u20132175","journal-title":"FEBS J"},{"key":"1155_CR38","doi-asserted-by":"crossref","unstructured":"Saumell-Esnaola M, Barrondo S, Garcia Del Cano G, Goicolea MA, Salles J, Lutz B, Monory K (2021) Subsynaptic distribution, lipid raft targeting and g protein-dependent signalling of the type 1 cannabinoid receptor in synaptosomes from the mouse hippocampus and frontal cortex. Molecules 26","DOI":"10.3390\/molecules26226897"},{"key":"1155_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrneurol.2016.53","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC (2016) HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. Nat Rev Neurol 12:309","journal-title":"Nat Rev Neurol"},{"key":"1155_CR40","doi-asserted-by":"crossref","unstructured":"Seibenhener ML, Wooten MC (2015) Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp e52434","DOI":"10.3791\/52434-v"},{"key":"1155_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/10253890.2018.1438405","volume":"21","author":"O Sturman","year":"2018","unstructured":"Sturman O, Germain PL, Bohacek J (2018) Exploratory rearing: a context- and stress-sensitive behavior recorded in the open-field test. Stress 21:443\u2013452","journal-title":"Stress"},{"key":"1155_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104502","volume":"130","author":"MK Swinton","year":"2019","unstructured":"Swinton MK, Carson A, Telese F, Sanchez AB, Soontornniyomkij B, Rad L, Batki I, Quintanilla B, Perez-Santiago J, Achim CL, Letendre S, Ellis RJ, Grant I, Murphy AN, Fields JA (2019) Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia. Neurobiol Dis 130:104502","journal-title":"Neurobiol Dis"},{"key":"1155_CR43","doi-asserted-by":"crossref","unstructured":"Swinton MK, Sundermann EE, Pedersen L, Nguyen JD, Grelotti DJ, Taffe MA, Iudicello JE, Fields JA (2021) Alterations in brain cannabinoid receptor levels are associated with HIV-Associated neurocognitive disorders in the art era: implications for therapeutic strategies targeting the endocannabinoid system. Viruses 13","DOI":"10.20944\/preprints202107.0665.v1"},{"key":"1155_CR44","doi-asserted-by":"crossref","unstructured":"Tadijan A, Vlasic I, Vlainic J, Dikic D, Orsolic N, Jazvinscak Jembrek M (2022) Intracellular molecular targets and signaling pathways involved in antioxidative and neuroprotective effects of cannabinoids in neurodegenerative conditions. Antioxidants (Basel) 11","DOI":"10.3390\/antiox11102049"},{"key":"1155_CR45","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s13365-017-0584-2","volume":"24","author":"VE Thaney","year":"2018","unstructured":"Thaney VE, Sanchez AB, Fields JA, Minassian A, Young JW, Maung R, Kaul M (2018) Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. J Neurovirol 24:156\u2013167","journal-title":"J Neurovirol"},{"key":"1155_CR46","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0006-8993(95)01197-8","volume":"706","author":"S Toggas","year":"1996","unstructured":"Toggas S, Masliah E, Mucke L (1996) Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor atagonist memantine. Brain Res 706:303\u2013307","journal-title":"Brain Res"},{"key":"1155_CR47","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/367188a0","volume":"367","author":"SM Toggas","year":"1994","unstructured":"Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188\u201393","journal-title":"Nature"},{"key":"1155_CR48","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3389\/fneur.2020.00840","volume":"11","author":"A Tripathi","year":"2020","unstructured":"Tripathi A, Thangaraj A, Chivero ET, Periyasamy P, Burkovetskaya ME, Niu F, Guo ML, Buch S (2020) N-Acetylcysteine Reverses Antiretroviral-Mediated Microglial Activation by Attenuating Autophagy-Lysosomal Dysfunction. Front Neurol 11:840","journal-title":"Front Neurol"},{"key":"1155_CR49","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bjp.0705667","volume":"141","author":"L Walter","year":"2004","unstructured":"Walter L, Stella N (2004) Cannabinoids and neuroinflammation. Br J Pharmacol 141:775\u201385","journal-title":"Br J Pharmacol"},{"key":"1155_CR50","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1017\/S1355617720001447","volume":"27","author":"CW Watson","year":"2021","unstructured":"Watson CW, Campbell LM, Sun-Suslow N, Hong S, Umlauf A, Ellis RJ, Iudicello JE, Letendre S, Marcotte TD, Heaton RK, Morgan EE, Grant I (2021) Daily Cannabis Use is Associated With Lower CNS Inflammation in People With HIV. J Int Neuropsychol Soc 27:661\u2013672","journal-title":"J Int Neuropsychol Soc"},{"key":"1155_CR51","doi-asserted-by":"crossref","unstructured":"Wu MM, Thayer SA (2020) HIV Tat protein selectively impairs cb(1) receptor-mediated presynaptic inhibition at excitatory but not inhibitory synapses. eNeuro 7","DOI":"10.1523\/ENEURO.0119-20.2020"},{"key":"1155_CR52","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s11481-017-9755-4","volume":"12","author":"P Xu","year":"2017","unstructured":"Xu P, Wang Y, Qin Z, Qiu L, Zhang M, Huang Y, Zheng JC (2017) Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In Vitro. J Neuroimmune Pharmacol 12:682\u2013692","journal-title":"J Neuroimmune Pharmacol"},{"key":"1155_CR53","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang Z, Wang KK (2015) Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci 38:364\u201374","journal-title":"Trends Neurosci"},{"key":"1155_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.806417","volume":"12","author":"AP Young","year":"2021","unstructured":"Young AP, Denovan-Wright EM (2021) The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation. Front Pharmacol 12:806417","journal-title":"Front Pharmacol"}],"updated-by":[{"DOI":"10.1007\/s13365-023-01192-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000}}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-023-01155-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-023-01155-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-023-01155-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T12:15:02Z","timestamp":1704370502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-023-01155-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1155"],"URL":"https:\/\/doi.org\/10.1007\/s13365-023-01155-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2652625\/v1","asserted-by":"object"}]},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13365-023-01192-6","URL":"https:\/\/doi.org\/10.1007\/s13365-023-01192-6","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UCSD is an Institutional Animal Care and Use Committee accredited institution and the Animal Subjects Committee approved the experimental protocol (UCSD IACUC Protocol\u00a0S02221) followed in all studies according to the Association for Assessment and Accreditation of Laboratory Animal Care International guidelines. All experiments were performed according to NIH recommendations for animal use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}